Program - angioplasty summit-tctap 2013
Program - angioplasty summit-tctap 2013
Program - angioplasty summit-tctap 2013
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Program</strong><br />
#3. What Is the Optimal<br />
Antiplatelet Therapy in High<br />
Risk Patient After DES<br />
Implantation?<br />
Co-sponsored by Korea Otsuka Pharmaceutical<br />
Co., Ltd.<br />
Room 1-1(Calla Room), Level 1<br />
Moderators: Alexandra J. Lansky<br />
Seong-Wook Park<br />
12:30 PM<br />
12:35 PM<br />
12:55 PM<br />
1:15 PM<br />
1:30 PM<br />
#4. NOBORI - Clinical Data Update<br />
Co-sponsored by Terumo Korea Corporation<br />
Room 2-1(Presidio 1 & 2), Level 2<br />
Moderator: Takeshi Kimura<br />
12:30 PM<br />
12:50 PM<br />
1:15 PM<br />
1:23 PM<br />
1:30 PM<br />
Welcome address<br />
Seong-Wook Park<br />
Tailoring Treatment to Risk in<br />
Antiplatelet Therapy<br />
Alexandra J. Lansky<br />
The Role of Triple Antiplatelet<br />
Therapy in Patients with High<br />
Risk<br />
Young-Hoon Jeong<br />
Q & A<br />
Adjourn<br />
Stentdesign Comparison and<br />
Clinical Perspectives<br />
Yutaka Hikichi<br />
NOBORI -Clinical Studies<br />
Updates<br />
Gian Battista Danzi<br />
Future Clinical Study for Nobori<br />
Stent in Korea<br />
Seung-Jung Park<br />
Discussion<br />
Adjourn<br />
#5. Beyond the Horizon - Inspire<br />
Your Confidence<br />
Co-sponsored by Boston Scientific Korea<br />
Symposium Arena, Level 3<br />
Moderators: Seung-Jung Park<br />
Patrick W. Serruys<br />
12:30 PM<br />
12:35 PM<br />
1:05 PM<br />
1:20 PM<br />
1:30 PM<br />
Opening Remarks & Welcome<br />
Address<br />
Seung-Jung Park<br />
SYNTAX - Data Synthesis and<br />
Clinical Recommendations<br />
Patrick W. Serruys<br />
Boston Scientific DES - Current<br />
& Future Perspectives<br />
Keith D. Dawkins<br />
Q & A<br />
Adjourn<br />
#6. Advances in the Treatment of<br />
Chronic Limb Ischemia -<br />
Current Treatment in CLI<br />
Co-sponsored by Johnson & Johnson Medical<br />
Korea (Endovascular)<br />
Tutorial Arena, Level 4<br />
Moderator: Taehoon Ahn<br />
Panelists: Seung-Whan Lee<br />
Seung Hyuk Choi<br />
Tae Won Kwon<br />
12:30 PM<br />
12:35 PM<br />
1:05 PM<br />
1:15 PM<br />
1:25 PM<br />
1:30 PM<br />
Opening Remark<br />
Taehoon Ahn<br />
Current Treatment in CLI<br />
Dierk Scheinert<br />
Improved Technical Success and<br />
Miterm Patency with Subintimal<br />
Angioplasty (Compared to<br />
Intraluminal Angioplasty in Long<br />
Femoropopliteal Occlusions)<br />
Young-Guk Ko<br />
Preliminary Result of Study for<br />
Prevalence of Peripheral Vascular<br />
Disease by for Screening Test<br />
Jang Yong Kim<br />
Q & A<br />
Adjourn<br />
Evening Satellite Symposia<br />
6:30 PM-9:00 PM<br />
#1. Design for Patient & Lesion<br />
Characteristic: Endeavor &<br />
Endeavor Resolute Perspective<br />
Co-sponsored by Medtronic, Inc.<br />
Coronary Arena, Level 1<br />
Co-Moderators: Yangsoo Jang<br />
Ian T. Meredith<br />
Panelists: Raoul Bonan<br />
Myeong-Chan Cho<br />
Hyo-Soo Kim<br />
Micheal Kang-Yin Lee<br />
Ki Bae Seung<br />
6:30 PM<br />
7:00 PM<br />
7:20 PM<br />
7:40 PM<br />
8:00 PM<br />
8:20 PM<br />
8:40 PM<br />
8:50 PM<br />
Dinner Reception & Welcome<br />
Address<br />
Endeavor Resolute: The Next<br />
Frontier<br />
Ian T. Meredith<br />
Endeavor <strong>Program</strong> Overview<br />
Martin B. Leon<br />
Safety Issue in DES Era<br />
David E. Kandzari<br />
Comparison of Sirolimus- and<br />
Paclitaxel-Eluting Stents vs<br />
Zotarolimus-Eluting Stents in<br />
Real World Practice: The ZEST<br />
Randomized Controlled Trial<br />
Seung-Jung Park<br />
What I like Most on Endeavor<br />
Stent Based on the DATE<br />
Registry<br />
Hyeon-Cheol Gwon<br />
Q&A<br />
Adjourn
Change language